Stock Price Quote

ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE368.155.75 (+1.59 %)
PREV CLOSE ( ) 362.40
OPEN PRICE ( ) 365.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 92243
TODAY'S LOW / HIGH ( )360.15 373.55
52 WK LOW / HIGH ( )319.4 668.85
NSE368.105.6 (+1.54 %)
PREV CLOSE( ) 362.50
OPEN PRICE ( ) 364.50
BID PRICE (QTY) 368.10 (2559)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3218921
TODAY'S LOW / HIGH( ) 360.25 373.65
52 WK LOW / HIGH ( )319 668.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103-20/71800000

Email investor.grievance@zyduscadila.com/dhavalsoni@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

23May Zydus Lifesciences zooms despite repor
Zydus Lifesciences is currently trading at Rs. 365.60, up by 8.45 points..
20May Zydus Lifesciences reports 41% fall in
Zydus Lifesciences has reported results for fourth quarter and year ende..
16May Zydus Lifesciences informs about post
Zydus Lifesciences has informed that the financial results of the compan..
13May Zydus Lifesciences launches Bemdac to
Zydus Lifesciences has launched Bemdac (Bempedoic acid), a new class of..
13May Zydus Lifesciences informs about press
Zydus Lifesciences has informed that it enclosed a copy of press release..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit24698579
Gross Profit 3465 11639
Operating Profit 511320968
Net Sales 2019379819

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  18191.80 (2.47%)
M.Cap ( in Cr)38656.31
Dr. Reddy's Lab (BSE)
peergroup  4351.10 (1.80%)
M.Cap ( in Cr)72413.55
Shilpa Medicare (BSE)
peergroup  453.25 (10.47%)
M.Cap ( in Cr)3934.30
Hikal (BSE)
peergroup  391.75 (6.69%)
M.Cap ( in Cr)4830.31
Kwality Pharma (BSE)
peergroup  417.10 (5.00%)
M.Cap ( in Cr)432.79

Shareholding Pattern

NON-INSTITUTION 9.69%
PROMOTERS 74.88%
FI/BANKS/INSURANCE 7.23%
MUTUAL FUNDS/UTI 5.55%
GOVERNMENT 0.08%
FII 0%

About Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd. was incorporated in the year 1995. Its today's share price is 368.15. Its current market capitalisation stands at Rs 37689.08 Cr. In the latest quarter, company has reported Gross Sales of Rs. 77904 Cr and Total Income of Rs.78706 Cr. The company's management includes Dhaval N Soni, Apurva S Diwanji, Dharmishta N Raval, Nitin R Desai, Bhadresh K Shah, Mukesh M Patel, Ganesh N Nayak, Sharvil P Patel, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of ZYDUSLIFE and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)